Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J B Hauptman

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal of Clinical Pharmacology|February 13, 1999
Long-term systemic exposure of orlistat, a lipase inhibitor, and its metabolites in obese patientsJ Zhi, T E Mulligan, J B Hauptman
The American Journal of Clinical Nutrition|January 1, 1992
Initial studies in humans with the novel gastrointestinal lipase inhibitor Ro 18-0647 (tetrahydrolipstatin)J B Hauptman, F S Jeunet, D Hartmann
Archives of Internal Medicine|December 1, 1983
Adrenergic blockade in pheochromocytomaR S Modlinger, N H Ertel, J B Hauptman
The American Journal of Clinical Nutrition|February 1, 1989
Serum triglyceride responsesJ J Demise, J B Hauptman, A W Dunton
Archives of Internal Medicine|December 1, 1983
Pheochromocytoma resistant to alpha-adrenergic blockadeJ B Hauptman, R S Modlinger, N H Ertel
Clinical Pharmacology and Therapeutics|July 1, 1994
Retrospective population-based analysis of the dose-response (fecal fat excretion) relationship of orlistat in normal and obese volunteersJ Zhi, A T Melia, R Guerciolini, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of Clinical Pharmacology|February 13, 1999
Long-term systemic exposure of orlistat, a lipase inhibitor, and its metabolites in obese patientsJ Zhi, T E Mulligan, J B Hauptman
The American Journal of Clinical Nutrition|January 1, 1992
Initial studies in humans with the novel gastrointestinal lipase inhibitor Ro 18-0647 (tetrahydrolipstatin)J B Hauptman, F S Jeunet, D Hartmann
Archives of Internal Medicine|December 1, 1983
Adrenergic blockade in pheochromocytomaR S Modlinger, N H Ertel, J B Hauptman
The American Journal of Clinical Nutrition|February 1, 1989
Serum triglyceride responsesJ J Demise, J B Hauptman, A W Dunton
Archives of Internal Medicine|December 1, 1983
Pheochromocytoma resistant to alpha-adrenergic blockadeJ B Hauptman, R S Modlinger, N H Ertel
Clinical Pharmacology and Therapeutics|July 1, 1994
Retrospective population-based analysis of the dose-response (fecal fat excretion) relationship of orlistat in normal and obese volunteersJ Zhi, A T Melia, R Guerciolini, et al.
Pageof 1